首页 > 最新文献

Biomedical Papers-Olomouc最新文献

英文 中文
Interventions for increasing medication adherence in heart failure patients: A narrative review. 提高心力衰竭患者服药依从性的干预措施:叙述性综述。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 Epub Date: 2024-07-16 DOI: 10.5507/bp.2024.022
Libor Jelinek, Jan Vaclavik, Marie Lazarova

Heart failure is one of the critical and most costly medical challenges of the 21st century. It is a chronic debilitating condition and adherence to medication, a precondition for successful treatment is often poor. There are various interventions for improving the adherence. Depending on the goal of the intervention, these are roughly patient centric, healthcare provider centric and system centric. We provide an overview of these interventions with a focus on effectiveness and appropriateness in different clinical situations. Their use can lead to improved patient outcomes and reduced economic burden of the disease.

心力衰竭是 21 世纪最严峻、最昂贵的医疗挑战之一。心力衰竭是一种使人衰弱的慢性病,而坚持服药是成功治疗的先决条件,但坚持服药的程度往往很低。有各种干预措施可以改善服药依从性。根据干预目标的不同,这些干预措施大致分为以患者为中心、以医疗服务提供者为中心和以系统为中心。我们将对这些干预措施进行概述,重点关注其在不同临床情况下的有效性和适宜性。使用这些干预措施可以改善患者的治疗效果,减轻疾病带来的经济负担。
{"title":"Interventions for increasing medication adherence in heart failure patients: A narrative review.","authors":"Libor Jelinek, Jan Vaclavik, Marie Lazarova","doi":"10.5507/bp.2024.022","DOIUrl":"10.5507/bp.2024.022","url":null,"abstract":"<p><p>Heart failure is one of the critical and most costly medical challenges of the 21st century. It is a chronic debilitating condition and adherence to medication, a precondition for successful treatment is often poor. There are various interventions for improving the adherence. Depending on the goal of the intervention, these are roughly patient centric, healthcare provider centric and system centric. We provide an overview of these interventions with a focus on effectiveness and appropriateness in different clinical situations. Their use can lead to improved patient outcomes and reduced economic burden of the disease.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"200-205"},"PeriodicalIF":0.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141635869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-of-care ultrasound (POCUS) in acute hospitalized older patients focused on hydration. 护理点超声(POCUS)在急性住院的老年患者中主要关注水合作用。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 Epub Date: 2023-10-03 DOI: 10.5507/bp.2023.038
Vladimir Hrabovsky, Martina Skrobankova, Zdenek Lys, Adela Vrtkova, Veronika Spacilova, Jan Vaclavik

Background: Acutely ill older patients frequently suffer not only from their acute disease, but also polymorbidity and frailty. Dehydration is another typical symptom, usually occurring in its both forms: low-intake dehydration and volume depletion. POCUS is goal-directed bedside ultrasound examination and several studies refer to its positive impact on hydration assessment. The aim of our study was to determine whether POCUS might influence (de)hydration diagnostics and/or treatments in older patients with acute illness.

Methods: We randomized 120 acutely ill patients, aged ≥65 years, into POCUS and non-POCUS groups. All participants underwent routine laboratory tests, including haematocrit, serum and urine osmolality, blood urea nitrogen (BUN), creatinine, BUN/creatinine ratio, and C-reactive protein (CRP). POCUS was performed twice during the first two days to determine chest and abdominal status, with inferior vena cava (IVC) measurements. Length of hospital stay (HL) and consumption of infused fluids (CIF) was evaluated too. Data were analysed with exploratory methods and appropriate statistics.

Results: Among all participants, the serum osmolality significantly correlated with age, BUN, creatinine and CIF. HL correlated with CRP and CIF. No significant correlations between IVC and other followed parameters were found. The POCUS group consumed significantly less infused fluids than the non-POCUS group, what could be influenced by POCUS examination of defined body compartments.

Conclusion: Dehydration is a common feature in older individuals and its diagnostics is rather complicated. The role of POCUS in assessing hydration status remains unclear. However, our study showed, that ultrasound assessment provides next important information for comprehensive understanding of clinical status in older patients and can be beneficial for optimizing the treatment strategy, including fluid management decisions.

背景:老年急性病患者经常不仅患有急性疾病,而且患有多发病和虚弱。脱水是另一种典型的症状,通常以两种形式出现:低摄入量脱水和体积衰竭。POCUS是一种目标导向的床边超声检查,一些研究指出它对水合作用评估有积极影响。我们研究的目的是确定POCUS是否会影响老年急性疾病患者的(脱水)诊断和/或治疗。方法:我们将120名年龄≥65岁的急性病患者随机分为POCUS和非POCUS组。所有参与者都接受了常规实验室测试,包括红细胞压积、血清和尿液渗透压、血尿素氮(BUN)、肌酸酐、BUN/肌酸酐比率和C反应蛋白(CRP)。前两天进行了两次POCUS,以确定胸部和腹部状态,并测量下腔静脉(IVC)。住院时间(HL)和输液消耗量(CIF)也进行了评估。采用探索性方法和适当的统计数据对数据进行分析。结果:在所有参与者中,血清渗透压与年龄、BUN、肌酐和CIF显著相关。HL与CRP和CIF呈正相关。IVC和其他后续参数之间没有发现显著的相关性。与非POCUS组相比,POCUS小组消耗的输注液明显较少,这可能受到POCUS对特定身体隔室检查的影响。结论:脱水是老年人的常见特征,其诊断相当复杂。POCUS在评估水合状态中的作用尚不清楚。然而,我们的研究表明,超声评估为全面了解老年患者的临床状况提供了下一个重要信息,并有利于优化治疗策略,包括液体管理决策。
{"title":"Point-of-care ultrasound (POCUS) in acute hospitalized older patients focused on hydration.","authors":"Vladimir Hrabovsky, Martina Skrobankova, Zdenek Lys, Adela Vrtkova, Veronika Spacilova, Jan Vaclavik","doi":"10.5507/bp.2023.038","DOIUrl":"10.5507/bp.2023.038","url":null,"abstract":"<p><strong>Background: </strong>Acutely ill older patients frequently suffer not only from their acute disease, but also polymorbidity and frailty. Dehydration is another typical symptom, usually occurring in its both forms: low-intake dehydration and volume depletion. POCUS is goal-directed bedside ultrasound examination and several studies refer to its positive impact on hydration assessment. The aim of our study was to determine whether POCUS might influence (de)hydration diagnostics and/or treatments in older patients with acute illness.</p><p><strong>Methods: </strong>We randomized 120 acutely ill patients, aged ≥65 years, into POCUS and non-POCUS groups. All participants underwent routine laboratory tests, including haematocrit, serum and urine osmolality, blood urea nitrogen (BUN), creatinine, BUN/creatinine ratio, and C-reactive protein (CRP). POCUS was performed twice during the first two days to determine chest and abdominal status, with inferior vena cava (IVC) measurements. Length of hospital stay (HL) and consumption of infused fluids (CIF) was evaluated too. Data were analysed with exploratory methods and appropriate statistics.</p><p><strong>Results: </strong>Among all participants, the serum osmolality significantly correlated with age, BUN, creatinine and CIF. HL correlated with CRP and CIF. No significant correlations between IVC and other followed parameters were found. The POCUS group consumed significantly less infused fluids than the non-POCUS group, what could be influenced by POCUS examination of defined body compartments.</p><p><strong>Conclusion: </strong>Dehydration is a common feature in older individuals and its diagnostics is rather complicated. The role of POCUS in assessing hydration status remains unclear. However, our study showed, that ultrasound assessment provides next important information for comprehensive understanding of clinical status in older patients and can be beneficial for optimizing the treatment strategy, including fluid management decisions.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"256-261"},"PeriodicalIF":0.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41169789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of prior oral anticoagulation on admission stroke severity in patients with atrial fibrillation. 既往口服抗凝药对心房颤动患者入院时中风严重程度的影响。
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-07-16 DOI: 10.5507/bp.2024.024
David Franc, Daniel Sanak, Michal Kral, Martin Hutyra, Milos Taborsky, Petra Divisova, Jana Zapletalova

Background and aims: In patients with atrial fibrillation, oral anticoagulation therapy is indicated for both primary and secondary prevention of stroke/systemic embolism. Though direct oral anticoagulants with greater safety and efficacy than warfarin were introduced into clinical practice at the beginning of the last decade, even now not all patients with AF have adequate preventative anticoagulant treatment. The primary goal of this study was to evaluate the impact of prior use of oral anticoagulants on admission stroke severity in those with AF. Other aims were, inter alia, to assess the trend in atrial fibrillation prevalence in the years of the HISTORY trials 2012-2021 carried out in the Czech Republic and use of oral anticoagulants (OAC) in ischemic stroke (IS) patients.

Methods: We analyzed consecutive ischemic stroke patients who had been enrolled in the HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (identifier NCT01541163) in the year 2012 and carried out a yearly comparison (detailed in the text).

Results: In total, there were 1059 patients (55.9% males, mean age 71.7±12.8). There was no significant difference over the time period in rate of known (18.3 vs. 16.5%, P=0.442) or newly detected AF (17.0 vs. 16.0%, P=0.665), but sigificantly more patients with known AF were treated with oral anticoagulants before IS in the year 2021 (32.1 vs. 70.7%, P<0.0001), and direct oral anticoagulants (3.6 vs. 35.4%, P<0.0001). The number of patients with atrial fibrillation had not changed significantly over the years (26.2 vs. 31.3%). Patients on OAC had a lower median admission score on the National Institutes of Health Stroke Scale (NIHSS) than those not using an oral anticoagulant (6 vs. 16, P=0.0004) in 2021.

Conclusions: There was no significant upward trend in atrial fibrillation in stroke patients admitted between 2012 and 2021, but patients with known AF were significantly more frequently treated with oral anticoagulants and direct oral anticoagulants (DOAC) in 2021. Patients on OAC had lower admission NIHSS scores than those not using any anticoagulent in the year 2021. The difference in the median admission NIHSS between the patients on OAC and those without OAC treatment was not significant in the year 2012 (6 vs. 12, P=0.066). This might be related to the fact that substantially fewer patients in 2012 were on DOACs, which are considered more effective than warfarin.

背景和目的:对于心房颤动患者,口服抗凝疗法适用于中风/系统性栓塞的一级和二级预防。虽然比华法林更安全、更有效的直接口服抗凝药在上个十年初被引入临床实践,但即使是现在,也并非所有心房颤动患者都能得到充分的预防性抗凝治疗。本研究的主要目的是评估先前使用口服抗凝药对房颤患者入院时中风严重程度的影响。其他目的还包括评估 2012-2021 年捷克共和国 HISTORY 试验期间心房颤动患病率的变化趋势,以及缺血性中风(IS)患者口服抗凝剂(OAC)的使用情况:我们分析了 2012 年在 ClinicalTrials.gov 上注册的 HISTORY(心脏与缺血性脑卒中关系研究)研究(标识符 NCT01541163)中登记的连续缺血性脑卒中患者,并进行了年度比较(详见正文):共有 1059 名患者(55.9% 为男性,平均年龄为 71.7±12.8)。在此期间,已知房颤率(18.3% 对 16.5%,P=0.442)或新发现房颤率(17.0% 对 16.0%,P=0.665)无明显差异,但在 2021 年 IS 前接受口服抗凝剂治疗的已知房颤患者明显增多(32.1% 对 70.7%,PConclusions):2012 年至 2021 年期间收治的脑卒中患者中,心房颤动患者人数没有明显上升趋势,但 2021 年已知心房颤动患者接受口服抗凝药和直接口服抗凝药(DOAC)治疗的人数明显增多。与未使用任何抗凝剂的患者相比,使用口服抗凝剂的患者在2021年的入院NIHSS评分更低。在2012年,使用OAC和未使用OAC治疗的患者入院NIHSS中位数差异不显著(6 vs. 12,P=0.066)。这可能与2012年使用DOAC的患者人数大幅减少有关,而DOAC被认为比华法林更有效。
{"title":"Impact of prior oral anticoagulation on admission stroke severity in patients with atrial fibrillation.","authors":"David Franc, Daniel Sanak, Michal Kral, Martin Hutyra, Milos Taborsky, Petra Divisova, Jana Zapletalova","doi":"10.5507/bp.2024.024","DOIUrl":"https://doi.org/10.5507/bp.2024.024","url":null,"abstract":"<p><strong>Background and aims: </strong>In patients with atrial fibrillation, oral anticoagulation therapy is indicated for both primary and secondary prevention of stroke/systemic embolism. Though direct oral anticoagulants with greater safety and efficacy than warfarin were introduced into clinical practice at the beginning of the last decade, even now not all patients with AF have adequate preventative anticoagulant treatment. The primary goal of this study was to evaluate the impact of prior use of oral anticoagulants on admission stroke severity in those with AF. Other aims were, inter alia, to assess the trend in atrial fibrillation prevalence in the years of the HISTORY trials 2012-2021 carried out in the Czech Republic and use of oral anticoagulants (OAC) in ischemic stroke (IS) patients.</p><p><strong>Methods: </strong>We analyzed consecutive ischemic stroke patients who had been enrolled in the HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (identifier NCT01541163) in the year 2012 and carried out a yearly comparison (detailed in the text).</p><p><strong>Results: </strong>In total, there were 1059 patients (55.9% males, mean age 71.7±12.8). There was no significant difference over the time period in rate of known (18.3 vs. 16.5%, P=0.442) or newly detected AF (17.0 vs. 16.0%, P=0.665), but sigificantly more patients with known AF were treated with oral anticoagulants before IS in the year 2021 (32.1 vs. 70.7%, P<0.0001), and direct oral anticoagulants (3.6 vs. 35.4%, P<0.0001). The number of patients with atrial fibrillation had not changed significantly over the years (26.2 vs. 31.3%). Patients on OAC had a lower median admission score on the National Institutes of Health Stroke Scale (NIHSS) than those not using an oral anticoagulant (6 vs. 16, P=0.0004) in 2021.</p><p><strong>Conclusions: </strong>There was no significant upward trend in atrial fibrillation in stroke patients admitted between 2012 and 2021, but patients with known AF were significantly more frequently treated with oral anticoagulants and direct oral anticoagulants (DOAC) in 2021. Patients on OAC had lower admission NIHSS scores than those not using any anticoagulent in the year 2021. The difference in the median admission NIHSS between the patients on OAC and those without OAC treatment was not significant in the year 2012 (6 vs. 12, P=0.066). This might be related to the fact that substantially fewer patients in 2012 were on DOACs, which are considered more effective than warfarin.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141635868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of fine-needle aspiration biopsy (FNAB) in parotid pleomorphic adenoma diagnosis and management. 细针穿刺活检(FNAB)在腮腺多形性腺瘤诊断和管理中的实用性。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-06-01 Epub Date: 2023-07-10 DOI: 10.5507/bp.2023.027
Alzbeta Fikova, Stepan Novak, David Kalfert, Martin Kuchar, Michal Zabrodsky, Lucie Dostalova, Jan Balko, Jan Plzak

Purpose: Pleomorphic adenoma (PA), the most common benign tumour of the parotid gland, requires accurate preoperative diagnosis owing to its capacity for malignant transformation. The aim of this study was to evaluate our experience with ultrasound-guided fine-needle aspiration biopsy (FNAB) in the diagnostic algorithm for patients with PA and to assess clinical outcomes for those with different surgical approaches.

Material and methods: We carried out a retrospective analysis of patients treated for parotid gland mass between 2010 and 2016. These had had preoperative FNAB and had undergone subsequent surgery.

Results: 165 patients had FNAB with the result of PA and the definitive histology confirmed PA in 159 cases (96.4%). On the other hand, in 179 patients, the definitive histology showed PA and the preoperative FNAB result corresponded in 159 cases (88.9%). The measured sensitivity, specificity and accuracy of ultrasound-guided FNAB in the diagnosis of PA were, respectively, 88.83%, 96.23% and 92.31%. Most of the patients underwent superficial or partial superficial parotidectomy, followed by extracapsular dissection which was associated with statistically lower risk of facial nerve injury (P=0.04).

Conclusion: Ultrasound-guided FNAB is simple, accurate and valuable in the diagnosis of PA and provides results that can lead to the choice of less invasive operative treatment.

目的:腮腺多形性腺瘤(PA)是腮腺最常见的良性肿瘤,由于其具有恶变能力,因此需要准确的术前诊断。本研究旨在评估超声引导下细针穿刺活检(FNAB)在PA患者诊断算法中的应用经验,并评估不同手术方法的临床效果:我们对2010年至2016年间接受治疗的腮腺肿块患者进行了回顾性分析。这些患者在术前进行了FNAB检查,并接受了后续手术:165例患者的FNAB结果为PA,159例(96.4%)的最终组织学结果证实为PA。另一方面,在 179 例患者中,明确组织学显示 PA 与术前 FNAB 结果相符的有 159 例(88.9%)。经测量,超声引导 FNAB 诊断 PA 的敏感性、特异性和准确性分别为 88.83%、96.23% 和 92.31%。大多数患者接受了浅表或部分浅表腮腺切除术,随后进行了囊外剥离术,从统计学角度看,面神经损伤的风险较低(P=0.04):结论:超声引导下的 FNAB 诊断 PA 简单、准确且有价值,其结果可帮助选择创伤较小的手术治疗方法。
{"title":"Utility of fine-needle aspiration biopsy (FNAB) in parotid pleomorphic adenoma diagnosis and management.","authors":"Alzbeta Fikova, Stepan Novak, David Kalfert, Martin Kuchar, Michal Zabrodsky, Lucie Dostalova, Jan Balko, Jan Plzak","doi":"10.5507/bp.2023.027","DOIUrl":"10.5507/bp.2023.027","url":null,"abstract":"<p><strong>Purpose: </strong>Pleomorphic adenoma (PA), the most common benign tumour of the parotid gland, requires accurate preoperative diagnosis owing to its capacity for malignant transformation. The aim of this study was to evaluate our experience with ultrasound-guided fine-needle aspiration biopsy (FNAB) in the diagnostic algorithm for patients with PA and to assess clinical outcomes for those with different surgical approaches.</p><p><strong>Material and methods: </strong>We carried out a retrospective analysis of patients treated for parotid gland mass between 2010 and 2016. These had had preoperative FNAB and had undergone subsequent surgery.</p><p><strong>Results: </strong>165 patients had FNAB with the result of PA and the definitive histology confirmed PA in 159 cases (96.4%). On the other hand, in 179 patients, the definitive histology showed PA and the preoperative FNAB result corresponded in 159 cases (88.9%). The measured sensitivity, specificity and accuracy of ultrasound-guided FNAB in the diagnosis of PA were, respectively, 88.83%, 96.23% and 92.31%. Most of the patients underwent superficial or partial superficial parotidectomy, followed by extracapsular dissection which was associated with statistically lower risk of facial nerve injury (P=0.04).</p><p><strong>Conclusion: </strong>Ultrasound-guided FNAB is simple, accurate and valuable in the diagnosis of PA and provides results that can lead to the choice of less invasive operative treatment.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"156-161"},"PeriodicalIF":0.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9768230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
B cell subsets reconstitution and immunoglobulin levels in children and adolescents with B non-Hodgkin lymphoma after treatment with single anti CD20 agent dose included in chemotherapeutic protocols: single center experience and review of the literature. 儿童和青少年 B 型非霍奇金淋巴瘤患者在接受化疗方案中包含的单剂量抗 CD20 药物治疗后的 B 细胞亚群重建和免疫球蛋白水平:单中心经验和文献综述。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-06-01 Epub Date: 2023-05-23 DOI: 10.5507/bp.2023.021
Eva Hlavackova, Zdenka Krenova, Arpad Kerekes, Peter Slanina, Marcela Vlkova

Background: RTX, an anti-CD20 monoclonal antibody, added to chemotherapy has proven to be effective in children and adolescents with high-grade, high-risk and matured non-Hodgkin lymphoma. RTX leads to prompt CD19+ B lymphocyte depletion. However, despite preserved immunoglobulin production by long-lived plasmablasts after treatment, patients remain at risk of prolonged hypogammaglobulinemia. Further, there are few general guidelines for immunology laboratories and clinical feature monitoring after B cell-targeted therapies. The aim of this paper is to describe B cell reconstitution and immunoglobulin levels after pediatric B-NHL protocols, that included a single RTX dose and to review the literature.

Methods: A retrospective single-center study on the impact of a single RTX dose included in a chemotherapeutic pediatric B Non-Hodgkin Lymphoma (B-NHL) treatment protocols. Immunology laboratory and clinical features were evaluated over an eight hundred days follow-up (FU) period, after completing B-NHL treatment.

Results: Nineteen patients (fifteen Burkitt lymphoma, three Diffuse large B cell lymphoma, and one Marginal zone B cell lymphoma) fulfilled the inclusion criteria. Initiation of B cell subset reconstitution occurred a median of three months after B-NHL treatment. Naïve and transitional B cells declined over the FU in contrast to the marginal zone and the switched memory B cell increase. The percentage of patients with IgG, IgA, and IgM hypogammaglobulinemia declined consistently over the FU. Prolonged IgG hypogammaglobulinemia was detectable in 9%, IgM in 13%, and IgA in 25%. All revaccinated patients responded to protein-based vaccines by specific IgG antibody production increase. Following antibiotic prophylaxes, none of the patients with hypogammaglobulinemia manifested with either a severe or opportunistic infection course.

Conclusion: The addition of a single RTX dose to the chemotherapeutic treatment protocols was not shown to increase the risk of developing secondary antibody deficiency in B-NHL pediatric patients. Observed prolonged hypogammaglobulinemia remained clinically silent. However interdisciplinary agreement on regular long-term immunology FU after anti-CD20 agent treatment is required.

背景:RTX是一种抗CD20单克隆抗体,在化疗中加入RTX已被证明对患有高级别、高风险和成熟期非霍奇金淋巴瘤的儿童和青少年有效。RTX 可迅速消耗 CD19+ B 淋巴细胞。然而,尽管治疗后长寿命浆细胞仍能产生免疫球蛋白,但患者仍面临长期低丙种球蛋白血症的风险。此外,关于 B 细胞靶向疗法后免疫学实验室和临床特征监测的通用指南也很少。本文旨在描述小儿 B-NHL 方案(包括单剂量 RTX)后的 B 细胞重建和免疫球蛋白水平,并回顾相关文献:方法:这是一项单中心回顾性研究,研究对象是化疗小儿B型非霍奇金淋巴瘤(B-NHL)治疗方案中单次RTX剂量的影响。在完成 B-NHL 治疗后的八百天随访期间,对免疫学实验室和临床特征进行了评估:19名患者(15名伯基特淋巴瘤患者、3名弥漫大B细胞淋巴瘤患者和1名边缘区B细胞淋巴瘤患者)符合纳入标准。B细胞亚群重建开始于B-NHL治疗后的中位三个月。与边缘区和转换记忆B细胞的增加形成鲜明对比的是,新生和过渡性B细胞在FU期间减少。IgG、IgA和IgM低丙种球蛋白血症患者的比例在整个治疗期间持续下降。9% 的患者可检测到长期的 IgG 低丙种球蛋白血症,13% 的患者可检测到 IgM 低丙种球蛋白血症,25% 的患者可检测到 IgA 低丙种球蛋白血症。所有重新接种疫苗的患者都对基于蛋白质的疫苗产生了特异性 IgG 抗体。在接受抗生素预防治疗后,没有一名低丙种球蛋白血症患者出现严重感染或机会性感染:结论:在化疗方案中加入单剂量 RTX 并不会增加 B-NHL 儿科患者出现继发性抗体缺乏的风险。观察到的长期低丙种球蛋白血症在临床上仍无症状。不过,需要就抗CD20药物治疗后定期进行长期免疫学检查达成跨学科共识。
{"title":"B cell subsets reconstitution and immunoglobulin levels in children and adolescents with B non-Hodgkin lymphoma after treatment with single anti CD20 agent dose included in chemotherapeutic protocols: single center experience and review of the literature.","authors":"Eva Hlavackova, Zdenka Krenova, Arpad Kerekes, Peter Slanina, Marcela Vlkova","doi":"10.5507/bp.2023.021","DOIUrl":"10.5507/bp.2023.021","url":null,"abstract":"<p><strong>Background: </strong>RTX, an anti-CD20 monoclonal antibody, added to chemotherapy has proven to be effective in children and adolescents with high-grade, high-risk and matured non-Hodgkin lymphoma. RTX leads to prompt CD19+ B lymphocyte depletion. However, despite preserved immunoglobulin production by long-lived plasmablasts after treatment, patients remain at risk of prolonged hypogammaglobulinemia. Further, there are few general guidelines for immunology laboratories and clinical feature monitoring after B cell-targeted therapies. The aim of this paper is to describe B cell reconstitution and immunoglobulin levels after pediatric B-NHL protocols, that included a single RTX dose and to review the literature.</p><p><strong>Methods: </strong>A retrospective single-center study on the impact of a single RTX dose included in a chemotherapeutic pediatric B Non-Hodgkin Lymphoma (B-NHL) treatment protocols. Immunology laboratory and clinical features were evaluated over an eight hundred days follow-up (FU) period, after completing B-NHL treatment.</p><p><strong>Results: </strong>Nineteen patients (fifteen Burkitt lymphoma, three Diffuse large B cell lymphoma, and one Marginal zone B cell lymphoma) fulfilled the inclusion criteria. Initiation of B cell subset reconstitution occurred a median of three months after B-NHL treatment. Naïve and transitional B cells declined over the FU in contrast to the marginal zone and the switched memory B cell increase. The percentage of patients with IgG, IgA, and IgM hypogammaglobulinemia declined consistently over the FU. Prolonged IgG hypogammaglobulinemia was detectable in 9%, IgM in 13%, and IgA in 25%. All revaccinated patients responded to protein-based vaccines by specific IgG antibody production increase. Following antibiotic prophylaxes, none of the patients with hypogammaglobulinemia manifested with either a severe or opportunistic infection course.</p><p><strong>Conclusion: </strong>The addition of a single RTX dose to the chemotherapeutic treatment protocols was not shown to increase the risk of developing secondary antibody deficiency in B-NHL pediatric patients. Observed prolonged hypogammaglobulinemia remained clinically silent. However interdisciplinary agreement on regular long-term immunology FU after anti-CD20 agent treatment is required.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"167-176"},"PeriodicalIF":0.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9888669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High pre-transplant Mucosal Associated Invariant T Cell (MAIT) count predicts favorable course of myeloid aplasia. 移植前粘膜相关不变性 T 细胞(MAIT)计数高,预示着骨髓再生障碍的病程有利。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-06-01 Epub Date: 2023-03-10 DOI: 10.5507/bp.2023.011
Ivana Karlova Zubata, Jitka Smetanova Brozova, Tomas Karel, Barbora Bacova, Jan Novak

Aims: Mucosal Associated Invariant T (MAIT) cells are unconventional T cells with anti-infective potential. MAIT cells detect and fight against microbes on mucosal surfaces and in peripheral tissues. Previous works suggested that MAIT cells survive exposure to cytotoxic drugs in these locations. We sought to determine if they maintain their anti-infective functions after myeloablative chemotherapy.

Methods: We correlated the amount of MAIT cells (measured by flow cytometry) in the peripheral blood of 100 adult patients before the start of myeloablative conditioning plus autologous stem cell transplantation with the clinical and laboratory outcomes of aplasia.

Results: The amount of MAIT cells negatively correlated with peak C-reactive protein level and the amount of red blood cell transfusion units resulting in earlier discharge of patients with the highest amount of MAIT cells.

Conclusion: This work suggests the anti-infectious potential of MAIT cells is maintained during myeloid aplasia.

目的:粘膜相关不变性 T 细胞(MAIT)是具有抗感染潜能的非常规 T 细胞。MAIT 细胞能检测并对抗粘膜表面和外周组织中的微生物。以前的研究表明,MAIT 细胞在这些部位暴露于细胞毒性药物后仍能存活。我们试图确定 MAIT 细胞在髓鞘脱落化疗后是否仍能保持其抗感染功能:方法:我们将100名成年患者在开始进行髓脱落调理加自体干细胞移植前外周血中MAIT细胞的数量(通过流式细胞术测量)与再生障碍的临床和实验室结果进行了相关分析:结果:MAIT细胞的数量与C反应蛋白峰值水平和红细胞输血单位数量呈负相关,导致MAIT细胞数量最多的患者提前出院:结论:这项研究表明,MAIT细胞的抗感染潜能在骨髓增生过程中得以保持。
{"title":"High pre-transplant Mucosal Associated Invariant T Cell (MAIT) count predicts favorable course of myeloid aplasia.","authors":"Ivana Karlova Zubata, Jitka Smetanova Brozova, Tomas Karel, Barbora Bacova, Jan Novak","doi":"10.5507/bp.2023.011","DOIUrl":"10.5507/bp.2023.011","url":null,"abstract":"<p><strong>Aims: </strong>Mucosal Associated Invariant T (MAIT) cells are unconventional T cells with anti-infective potential. MAIT cells detect and fight against microbes on mucosal surfaces and in peripheral tissues. Previous works suggested that MAIT cells survive exposure to cytotoxic drugs in these locations. We sought to determine if they maintain their anti-infective functions after myeloablative chemotherapy.</p><p><strong>Methods: </strong>We correlated the amount of MAIT cells (measured by flow cytometry) in the peripheral blood of 100 adult patients before the start of myeloablative conditioning plus autologous stem cell transplantation with the clinical and laboratory outcomes of aplasia.</p><p><strong>Results: </strong>The amount of MAIT cells negatively correlated with peak C-reactive protein level and the amount of red blood cell transfusion units resulting in earlier discharge of patients with the highest amount of MAIT cells.</p><p><strong>Conclusion: </strong>This work suggests the anti-infectious potential of MAIT cells is maintained during myeloid aplasia.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"139-146"},"PeriodicalIF":0.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9084716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum concentrations of 25-OH vitamin D and the pro-inflammatory interleukins IL-17, IL-23, and IL-18 in patients with plaque psoriasis. 斑块型银屑病患者血清25-OH维生素D和促炎白介素IL-17、IL-23和IL-18的浓度
IF 0.7 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-06-01 Epub Date: 2023-11-14 DOI: 10.5507/bp.2023.043
Maria Ganeva, Zhivka Tsokeva, Tanya Gancheva, Evgeniya Hristakieva, Vanya Tsoneva, Irena Manolova

Aims: The present study aimed to assess vitamin D status and serum concentrations of pro-inflammatory cytokines IL-17, Il-23, and IL-18 in patients with chronic plaque psoriasis and their association with various demographic and clinical characteristics.

Methods: The study was conducted during the autumn/winter period on 48 patients with chronic plaque psoriasis and 48 controls. Total serum 25(OH)D level was determined with Roche Elecsys® 2010 Vitamin D total assay. Commercial ELISA kits were used for quantifying the serum levels of IL-17A, IL-18, and IL-23.

Results: Serum 25(OH)D had a median value of 16.95 ng/mL (IQR 10.8-23.50) for patients with psoriasis and 18.80 ng/mL (IQR 15.45-25.85) for the control group (P=0.09). A moderate negative correlation was found between PASI score and 25(OH)D levels (rs=-0.34; P=0.02). The serum levels of IL-17 (P=0.001), IL-23 (P=0.01) and IL-18 (P=0.02) were significantly higher in the patient group compared to controls. IL-17 concentrations were higher in patients with moderate to severe psoriasis compared to patients with mild psoriasis (P=0.003). No significant correlations were detected between the serum concentrations of 25(ОH)D and IL-17, IL-23, and IL-18.

Conclusion: It was confirmed that IL-17 serum level is associated with psoriasis severity. Measurement of 25(OH)D serum concentration can be useful in patients with moderate to severe psoriasis with or without comorbidities. A direct association between 25(OH)D serum concentration and the serum concentrations of IL-17, IL-23, or IL-18 was not identified in this study.

目的:本研究旨在评估慢性斑块型银屑病患者的维生素D状态和血清中促炎细胞因子IL-17、Il-23和IL-18的浓度及其与各种人口统计学和临床特征的关系。方法:在秋季/冬季对48例慢性斑块型银屑病患者和48例对照组进行研究。采用罗氏Elecsys®2010维生素D总测定法测定血清总25(OH)D水平。商用ELISA试剂盒用于定量血清IL-17A、IL-18和IL-23的水平。结果:银屑病患者血清25(OH)D中位数为16.95 ng/mL (IQR 10.8 ~ 23.50),对照组血清25(OH)D中位数为18.80 ng/mL (IQR 15.45 ~ 25.85) (P=0.09)。PASI评分与25(OH)D水平呈中度负相关(rs=-0.34;P = 0.02)。患者组血清IL-17 (P=0.001)、IL-23 (P=0.01)和IL-18 (P=0.02)水平均显著高于对照组。中重度银屑病患者IL-17浓度高于轻度银屑病患者(P=0.003)。血清25(ОH)D与IL-17、IL-23、IL-18浓度无显著相关性。结论:血清IL-17水平与银屑病严重程度相关。25(OH)D血清浓度测量可用于有或无合并症的中度至重度牛皮癣患者。25(OH)D血清浓度与IL-17、IL-23或IL-18血清浓度之间没有直接关联。
{"title":"Serum concentrations of 25-OH vitamin D and the pro-inflammatory interleukins IL-17, IL-23, and IL-18 in patients with plaque psoriasis.","authors":"Maria Ganeva, Zhivka Tsokeva, Tanya Gancheva, Evgeniya Hristakieva, Vanya Tsoneva, Irena Manolova","doi":"10.5507/bp.2023.043","DOIUrl":"10.5507/bp.2023.043","url":null,"abstract":"<p><strong>Aims: </strong>The present study aimed to assess vitamin D status and serum concentrations of pro-inflammatory cytokines IL-17, Il-23, and IL-18 in patients with chronic plaque psoriasis and their association with various demographic and clinical characteristics.</p><p><strong>Methods: </strong>The study was conducted during the autumn/winter period on 48 patients with chronic plaque psoriasis and 48 controls. Total serum 25(OH)D level was determined with Roche Elecsys<sup>®</sup> 2010 Vitamin D total assay. Commercial ELISA kits were used for quantifying the serum levels of IL-17A, IL-18, and IL-23.</p><p><strong>Results: </strong>Serum 25(OH)D had a median value of 16.95 ng/mL (IQR 10.8-23.50) for patients with psoriasis and 18.80 ng/mL (IQR 15.45-25.85) for the control group (P=0.09). A moderate negative correlation was found between PASI score and 25(OH)D levels (r<sub>s</sub>=-0.34; P=0.02). The serum levels of IL-17 (P=0.001), IL-23 (P=0.01) and IL-18 (P=0.02) were significantly higher in the patient group compared to controls. IL-17 concentrations were higher in patients with moderate to severe psoriasis compared to patients with mild psoriasis (P=0.003). No significant correlations were detected between the serum concentrations of 25(ОH)D and IL-17, IL-23, and IL-18.</p><p><strong>Conclusion: </strong>It was confirmed that IL-17 serum level is associated with psoriasis severity. Measurement of 25(OH)D serum concentration can be useful in patients with moderate to severe psoriasis with or without comorbidities. A direct association between 25(OH)D serum concentration and the serum concentrations of IL-17, IL-23, or IL-18 was not identified in this study.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"124-131"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. 视黄醇和视黄酸在胰腺癌、2型糖尿病和慢性胰腺炎中的水平。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-06-01 Epub Date: 2023-12-06 DOI: 10.5507/bp.2023.049
Pavel Hrabak, Miroslava Zelenkova, Tomas Krechler, Jan Soupal, Michal Vocka, Tomas Hanus, Lubos Petruzelka, Stepan Svacina, Ales Zak, Tomas Zima, Marta Kalousova

Aims: Retinoids participate in multiple key processes in the human body e.g., vision, cell differentiation and embryonic development. There is growing evidence of the relationship between retinol, its active metabolite- all-trans retinoic acid (ATRA) - and several pancreatic disorders. Although low levels of ATRA in pancreatic ductal adenocarcinoma (PDAC) tissue have been reported, data on serum levels of ATRA in PDAC is still limited. The aim of our work was to determine serum concentrations of retinol and ATRA in patients with PDAC, type-2 diabetes mellitus (T2DM), chronic pancreatitis (CHP) and healthy controls.

Methods: High performance liquid chromatography with UV detection (HPLC) was used to measure serum levels of retinol and ATRA in 246 patients with different stages of PDAC, T2DM, CHP and healthy controls.

Results: We found a significant decrease in the retinol concentration in PDAC (0.44+/-0.18 mg/L) compared to T2DM (0.65+/-0.19 mg/L, P<0.001), CHP (0.60+/-0.18 mg/L, P< 0.001) and healthy controls (0.61+/-0.15 mg/L, P<0.001), significant decrease of ATRA levels in PDAC (1.14+/-0.49 ug/L) compared to T2DM (1.37+/-0.56 ug/L, P<0.001) and healthy controls(1.43+/-0.55 ug/L, P<0.001). Differences between early stages (I+II) of PDAC and non-carcinoma groups were not significant. We describe correlations between retinol, prealbumin and transferrin, and correlation of ATRA and IGFBP-2.

Conclusion: Significant decrease in retinol and ATRA levels in PDAC compared to T2DM, healthy individuals and/or CHP supports existing evidence of the role of retinoids in PDAC. However, neither ATRA nor retinol are suitable for detection of early PDAC. Correlation of ATRA levels and IGFBP-2 provides new information about a possible IGF and retinol relationship.

目的:类维生素a参与人体多个关键过程,如视觉、细胞分化和胚胎发育。越来越多的证据表明,视黄醇及其活性代谢物全反式视黄酸(ATRA)与几种胰腺疾病之间存在关系。尽管有报道称胰腺导管腺癌(PDAC)组织中ATRA水平较低,但PDAC中ATRA血清水平的数据仍然有限。本研究的目的是测定PDAC、2型糖尿病(T2DM)、慢性胰腺炎(CHP)和健康对照患者的血清视黄醇和ATRA浓度。方法:采用高效液相色谱-紫外检测法(HPLC)测定246例不同分期PDAC、T2DM、CHP患者及健康对照者血清视黄醇和ATRA水平。结果:我们发现,与T2DM (0.65+/-0.19 mg/L, P+/-0.18 mg/L, P< 0.001)和健康对照(0.61+/-0.15 mg/L, P+/-0.49 ug/L)相比,PDAC (1.37+/-0.56 ug/L, P+/-0.55 ug/L, P)中视黄醇和ATRA水平显著降低,与T2DM、健康个体和/或CHP相比,PDAC中视黄醇和ATRA水平显著降低,支持了类维生素a在PDAC中的作用的现有证据。然而,ATRA和视黄醇都不适合早期PDAC的检测。ATRA水平与IGFBP-2的相关性为IGF和视黄醇之间可能的关系提供了新的信息。
{"title":"Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis.","authors":"Pavel Hrabak, Miroslava Zelenkova, Tomas Krechler, Jan Soupal, Michal Vocka, Tomas Hanus, Lubos Petruzelka, Stepan Svacina, Ales Zak, Tomas Zima, Marta Kalousova","doi":"10.5507/bp.2023.049","DOIUrl":"10.5507/bp.2023.049","url":null,"abstract":"<p><strong>Aims: </strong>Retinoids participate in multiple key processes in the human body e.g., vision, cell differentiation and embryonic development. There is growing evidence of the relationship between retinol, its active metabolite- all-trans retinoic acid (ATRA) - and several pancreatic disorders. Although low levels of ATRA in pancreatic ductal adenocarcinoma (PDAC) tissue have been reported, data on serum levels of ATRA in PDAC is still limited. The aim of our work was to determine serum concentrations of retinol and ATRA in patients with PDAC, type-2 diabetes mellitus (T2DM), chronic pancreatitis (CHP) and healthy controls.</p><p><strong>Methods: </strong>High performance liquid chromatography with UV detection (HPLC) was used to measure serum levels of retinol and ATRA in 246 patients with different stages of PDAC, T2DM, CHP and healthy controls.</p><p><strong>Results: </strong>We found a significant decrease in the retinol concentration in PDAC (0.44<sup>+/-0.18</sup> mg/L) compared to T2DM (0.65<sup>+/-0.19</sup> mg/L, P<0.001), CHP (0.60<sup>+/-0.18</sup> mg/L, P< 0.001) and healthy controls (0.61<sup>+/-0.15</sup> mg/L, P<0.001), significant decrease of ATRA levels in PDAC (1.14<sup>+/-0.49</sup> ug/L) compared to T2DM (1.37<sup>+/-0.56</sup> ug/L, P<0.001) and healthy controls(1.43<sup>+/-0.55</sup> ug/L, P<0.001). Differences between early stages (I+II) of PDAC and non-carcinoma groups were not significant. We describe correlations between retinol, prealbumin and transferrin, and correlation of ATRA and IGFBP-2.</p><p><strong>Conclusion: </strong>Significant decrease in retinol and ATRA levels in PDAC compared to T2DM, healthy individuals and/or CHP supports existing evidence of the role of retinoids in PDAC. However, neither ATRA nor retinol are suitable for detection of early PDAC. Correlation of ATRA levels and IGFBP-2 provides new information about a possible IGF and retinol relationship.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"132-138"},"PeriodicalIF":0.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138500312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal microvascular abnormalities in major depression. 重度抑郁症患者视网膜微血管异常。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-06-01 Epub Date: 2023-07-17 DOI: 10.5507/bp.2023.026
Evgenii Sadykov, Ladislav Hosak, Alexandr Stepanov, Jana Zapletalova, Jan Studnicka

Background: The aim of our study was to find a possible association between retinal microvascular abnormality and major depression in a non-geriatric population.

Method: The participants with major depression were hospitalised at the University Hospital in Hradec Kralove, Department of Psychiatry. Retinal images were obtained using a stationary Fundus camera FF450 by Zeiss and a hand-held camera by oDocs.

Results: Fifty patients (men n=18, women n=32) aged 16 to 55 (men's average age 33.7±9.9 years, women's average age 37.9±11.5 years) were compared with fifty mentally healthy subjects (men n=28, women n=22) aged 18 to 61 (men's average age 35.3±9.2 years, women's average age 36.6±10.6 years) in a cross-sectional design. The patients were diagnosed with a single depressive episode (n=26) or a recurrent depressive disorder (n=24) according to the ICD-10 classification. Our results confirmed significant microvascular changes in the retina in patients with depressive disorder in comparison to the control group of mentally healthy subjects, with significantly larger arteriolar (P<0.0001) as well as venular (P<0.001-0.0001) calibres in major depression.

Conclusion: According to the literature, acute and chronic neuroinflammation is associated with changes in microvascular form and function. The endothelium becomes a major participant in the inflammatory response damaging the surrounding tissue and its function. Because the retina and brain tissue share a common embryonic origin, we suspect similar microvascular pathology in the retina and in the brain in major depression. Our results may contribute to a better understanding of depression etiopathogenesis and to its personalized treatment.

研究背景我们研究的目的是在非老年人群中发现视网膜微血管异常与重度抑郁症之间可能存在的联系:方法:重度抑郁症患者在赫拉德茨克拉罗夫大学医院精神病学系住院治疗。使用蔡司固定式眼底照相机 FF450 和 oDocs 手持式照相机获取视网膜图像:50名年龄在16至55岁之间的患者(男性18人,女性32人)(男性平均年龄为33.7±9.9岁,女性平均年龄为37.9±11.5岁)与50名年龄在18至61岁之间的精神健康受试者(男性28人,女性22人)(男性平均年龄为35.3±9.2岁,女性平均年龄为36.6±10.6岁)进行了横断面比较。根据 ICD-10 分类,患者被诊断为单次抑郁发作(26 人)或复发性抑郁障碍(24 人)。我们的研究结果证实,与精神健康的对照组相比,抑郁症患者视网膜的微血管发生了明显变化,动脉血管明显增大:根据文献,急性和慢性神经炎症与微血管形态和功能的变化有关。内皮是炎症反应的主要参与者,会损害周围组织及其功能。由于视网膜和脑组织具有共同的胚胎起源,我们怀疑重度抑郁症患者的视网膜和大脑中存在类似的微血管病理学。我们的研究结果可能有助于更好地理解抑郁症的发病机理和个性化治疗。
{"title":"Retinal microvascular abnormalities in major depression.","authors":"Evgenii Sadykov, Ladislav Hosak, Alexandr Stepanov, Jana Zapletalova, Jan Studnicka","doi":"10.5507/bp.2023.026","DOIUrl":"10.5507/bp.2023.026","url":null,"abstract":"<p><strong>Background: </strong>The aim of our study was to find a possible association between retinal microvascular abnormality and major depression in a non-geriatric population.</p><p><strong>Method: </strong>The participants with major depression were hospitalised at the University Hospital in Hradec Kralove, Department of Psychiatry. Retinal images were obtained using a stationary Fundus camera FF450 by Zeiss and a hand-held camera by oDocs.</p><p><strong>Results: </strong>Fifty patients (men n=18, women n=32) aged 16 to 55 (men's average age 33.7±9.9 years, women's average age 37.9±11.5 years) were compared with fifty mentally healthy subjects (men n=28, women n=22) aged 18 to 61 (men's average age 35.3±9.2 years, women's average age 36.6±10.6 years) in a cross-sectional design. The patients were diagnosed with a single depressive episode (n=26) or a recurrent depressive disorder (n=24) according to the ICD-10 classification. Our results confirmed significant microvascular changes in the retina in patients with depressive disorder in comparison to the control group of mentally healthy subjects, with significantly larger arteriolar (P<0.0001) as well as venular (P<0.001-0.0001) calibres in major depression.</p><p><strong>Conclusion: </strong>According to the literature, acute and chronic neuroinflammation is associated with changes in microvascular form and function. The endothelium becomes a major participant in the inflammatory response damaging the surrounding tissue and its function. Because the retina and brain tissue share a common embryonic origin, we suspect similar microvascular pathology in the retina and in the brain in major depression. Our results may contribute to a better understanding of depression etiopathogenesis and to its personalized treatment.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"147-155"},"PeriodicalIF":0.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9886823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacillus Calmette-Guérin pneumonitis after intravesical instillation: Report of two cases and a review of the literature. 膀胱内灌注后的卡介苗-格林芽孢杆菌肺炎:两个病例的报告和文献综述。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-06-01 Epub Date: 2023-01-02 DOI: 10.5507/bp.2022.051
Martina Spisarova, Stanislav Losse, Petr Jakubec, Igor Hartmann, Milan Kral, Jiri Ehrmann, Marek Szkorupa, Hana Studentova, Bohuslav Melichar

Objective: Intravesical administration of bacillus Calmette-Guérin is standard adjuvant treatment of non-muscle invasive bladder cancer. In spite of the fact that this immunotherapy is locoregional, there are still risk of some complications.

Methods: We describe two cases of systemic BCG infection after intravesical administration of BCG vaccine in patients with early stage of bladder cancer.

Results: Both patients suffered from systemic BCG infection manifesting as BCG pneumonitis. After standard therapy with antituberculotic agents, both of them fully recovered.

Conclusion: BCG infection can occur as a rare but potentially serious complication of this treatment procedure. Gravity of this side effect and its specific therapy require prompt and right diagnosis.

目的:膀胱内注射卡介苗是治疗非肌层浸润性膀胱癌的标准辅助疗法。尽管这种免疫疗法是局部性的,但仍有可能出现一些并发症:方法:我们描述了两例膀胱癌早期患者膀胱内注射卡介苗后发生全身卡介苗感染的病例:结果:两例患者均出现全身卡介苗感染,表现为卡介苗肺炎。结论:卡介苗感染是一种罕见的疾病:结论:卡介苗感染是这种治疗方法的一种罕见但潜在的严重并发症。结论:卡介苗感染是一种罕见但潜在的严重并发症,这种副作用的严重性和具体治疗方法需要及时和正确的诊断。
{"title":"Bacillus Calmette-Guérin pneumonitis after intravesical instillation: Report of two cases and a review of the literature.","authors":"Martina Spisarova, Stanislav Losse, Petr Jakubec, Igor Hartmann, Milan Kral, Jiri Ehrmann, Marek Szkorupa, Hana Studentova, Bohuslav Melichar","doi":"10.5507/bp.2022.051","DOIUrl":"10.5507/bp.2022.051","url":null,"abstract":"<p><strong>Objective: </strong>Intravesical administration of bacillus Calmette-Guérin is standard adjuvant treatment of non-muscle invasive bladder cancer. In spite of the fact that this immunotherapy is locoregional, there are still risk of some complications.</p><p><strong>Methods: </strong>We describe two cases of systemic BCG infection after intravesical administration of BCG vaccine in patients with early stage of bladder cancer.</p><p><strong>Results: </strong>Both patients suffered from systemic BCG infection manifesting as BCG pneumonitis. After standard therapy with antituberculotic agents, both of them fully recovered.</p><p><strong>Conclusion: </strong>BCG infection can occur as a rare but potentially serious complication of this treatment procedure. Gravity of this side effect and its specific therapy require prompt and right diagnosis.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"181-186"},"PeriodicalIF":0.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9078858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Papers-Olomouc
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1